AJCC Cancer Staging System: Cervix Uteri Protocol for Cancer Staging Documentation (Version 9 of the AJCC Cancer Staging System) (PDF)

AJCC Cancer Staging System: Cervix Uteri Protocol for Cancer Staging Documentation (Version 9 of the AJCC Cancer Staging System)

By Alexander B. Olawaiye, David G. Mutch, Priya Bhosale, Donna M. Gress, Jana Vandenberg, Brian A. Rous, Ian Hagemann, Christopher Otis, Daniel C. Sullivan, Mary Kay Washington

Version 9 of the American Joint Committee on Cancer (AJCC) Cancer Staging System for the Cervix Uteri. Version 9 Cervix Uteri content is presented in a streamlined, easy-to-use format, incorporates the 2018 Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging classification, as well as the World Health Organization (WHO) 2020 Classification of Tumors histology codes. Physicians, registrars, researchers, and other content users will be benefit from the updated Cervix Uteri content, including tables, explanatory notes and illustrations. Version 9 of the Cervix Uteri Cancer Staging System becomes effective on January 1, 2021 and replaces the 8th Edition Cervix Uteri cancer site content. All other disease sites in the 8th Edition Cancer Staging Manual remain current for 2021.

The American Joint Committee on Cancer (AJCC) is proud to present the latest edition of the Cancer Staging System for the Cervix Uteri. The Version 9 Cervix Uteri content is a must-have reference guide for physicians, registrars, researchers, and all other content users who specialize in the diagnosis and treatment of cervical cancer.

This streamlined, easy-to-use format of the Version 9 Cervix Uteri Cancer Staging System incorporates the latest 2018 Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) staging classification, as well as the World Health Organization (WHO) 2020 Classification of Tumors histology codes. The updated Cervix Uteri content provides comprehensive information on the diagnosis, staging, and management of cervical cancer, making it an essential bedside reference guide for clinicians.

Authored by Alexander B. Olawaiye, David G. Mutch, Priya Bhosale, Donna M. Gress, Jana Vandenberg, Brian A. Rous, Ian Hagemann, Christopher Otis, Daniel C. Sullivan, and Mary Kay Washington, this guide is a testament to the collaborative efforts of experts in the field.

The Version 9 Cervix Uteri Cancer Staging System, which officially goes live on January 1, 2021, has replaced the 8th Edition Cancer Staging Manual as the primary reference guide for this disease site. This updated edition provides clinicians with the most up-to-date information on the diagnosis, staging, and treatment of cervical cancer.

The content of this guide is presented in a concise and organized manner, which makes it easy to navigate and understand. Furthermore, the tables, explanatory notes, and illustrations help to simplify complex information, which makes it readily accessible to all content users.

The ASIN (Amazon Standard Identification Number) for this guide is B0932Q3LNB. The publisher, Independently published, has made the guide available in digital format comprising 39 pages. The language is English.

Having reviewed the Version 9 Cervix Uteri Cancer Staging System, it is clear that this guide is a valuable resource for clinicians, scientists, and all those involved in the management of cervical cancer. The authors and editors have done an excellent job in streamlining the content, making it easy to follow and understand.

The updated staging system, which combines the latest FIGO staging classification and WHO histology codes, provides a comprehensive approach to the diagnosis and management of cervical cancer. The guide’s comprehensive coverage of the disease site, including the updated classification system, ensures that clinicians can make accurate staging decisions.

Clinicians will also appreciate the downloadable digital format of this guide, which makes it easily accessible on their devices, irrespective of their location.

In conclusion, we highly recommend the Cervix Uteri Cancer Staging System Version 9 as an essential resource for clinicians, registrars, scientific researchers, and all other content users involved in the management of cervical cancer. We encourage all content users to consider purchasing this guide today to stay up-to-date with the latest developments in the diagnosis and treatment of cervical cancer.